Depressive symptoms and associated factors in systemic lupus erythematosus

Psychosomatics

Volumn 54, Issue 5, 2013, Pages 443-450

  Karol, David E ^a   Criscione Schreiber, Lisa G ^a   Lin, Min ^a   Clowse, Megan E B ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; PREDNISONE;

ADULT; ARTHRITIS; ARTICLE; BECK DEPRESSION INVENTORY; COHORT ANALYSIS; DEMOGRAPHY; DEPRESSION; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PAIN; PAIN ASSESSMENT; PRESCRIPTION; RASH; SELF REPORT; SLEDAI; SYSTEMIC LUPUS ERYTHEMATOSUS; VISUAL ANALOG SCALE;

ADULT; ARTHRITIS; COHORT STUDIES; DEPRESSION; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PAIN; PAIN MANAGEMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84883767993     PISSN: 00333182     EISSN: 15457206     Source Type: Journal    
DOI: 10.1016/j.psym.2012.09.004     Document Type: Article

References (33)

1. Stojanovich L., Zandman-Goddard G., Pavlovich S., Sikanich N. Psychiatric manifestations in systemic lupus erythematosus. Autoimmun Rev 2007, 6(6):421-426.
2. Bachen E.A., Chesney M.A., Criswell L.A. Prevalence of mood and anxiety disorders in women with systemic lupus erythematosus. Arthritis Rheum 2009, 61(6):822-829.
3. Kessler R.C., McGonagle K.A., Zhao S., Nelson C.B., Hughes M., Eshelman S., et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry 1994, 51(1):8-19.
4. Newman S. The psychology of rheumatic diseases. Baillieres Best Pract Res Clin Rheumatol 2000, 14(4):773-786.
5. Nery F.G., Borba E.F., Hatch J.P., Soares J.C., Bonfá E., Neto F.L. Major depressive disorder and disease activity in systemic lupus erythematosus. Compr Psychiatry 2007, 48(1):14-19.
6. Baker K., Pope J., Fortin P., Silverman E., Peschken C., et al. 1000 faces of lupus investigators; CaNIOS (Canadian Network for Improved Outcomes in SLE): Work disability in systemic lupus erythematosus is prevalent and associated with socio-demographic and disease related factors. Lupus 2009, 18(4):1281-1282. 1000 Faces of Lupus Investigators.
7. Julian L.J., Yelin E., Yazdany J., Panopalis P., Trupin L., Criswell L.A., et al. Depression, medication adherence, and service utilization in systemic lupus erythematosus. Arthritis Rheum 2009, 61(2):240-246.
8. Panopalis P., Yazdany J., Gillis J.Z., Julian L., Trupin L., Hersh A.O., et al. Health care costs and costs associated with changes in work productivity among persons with systemic lupus erythematosus. Arthritis Rheum 2008, 59(12):1788-1795.
9. Shortall E., Isenberg D., Newman S.P. Factors associated with mood and mood disorders in SLE. Lupus 1995, 4(4):272-279.
10. Jarpa E., Babul M., Calderón J., González M., Martínez M.E., Bravo-Zehnder M., et al. Common mental disorders and psychological distress in systemic lupus erythematosus are not associated with disease activity. Lupus 2011, 20(1):58-66.
11. Ward M.M., Marx A.S., Barry N.N. Psychological distress and changes in the activity of systemic lupus erythematosus. Rheumatology 2002, 41(2):184-188.
12. Nery F.G., Borba E.F., Viana V.S., Hatch J.P., Soares J.C., Bonfá E., et al. Prevalence of depressive and anxiety disorders in systemic lupus erythematosus and their association with anti-ribosomal P antibodies. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32(3):695-700.
13. Katon W.J., Lin E.H., Von Korff M., Ciechanowski P., Ludman E.J., Young B., et al. Collaborative care for patients with depression and chronic illnesses. N Engl J Med 2010, 363(27):2611-2620.
14. Lin E.H., Katon W., Von Korff M., Tang L., Williams J.W., Kroenke K., et al. Effect of improving depression care on pain and functional outcomes among older adults with arthritis: a randomized controlled trial. JAMA 2003, 290(18):2428-2429.
15. Tan E.M., Cohen A.S., Fries J.F., Masi A.T., McShane D.J., Rothfield N.F., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus (SLE). Arthritis Rheum 1982, 25(11):1271-1277.
16. Petri M., Buyon J., Kim M. Classification and definition of major flares in SLE clinical trials. Lupus 1999, 8(8):685-691.
17. Sackheim H. The definition and meaning of treatment-resistant depression. J Clin Psych 2001, 62(Suppl 16):10-17.
18. Beck A.T., Brown G.K., Steer R.A. Beck Depression Inventory-II (BDI-II) 1996, Psychological Corporation, San Antonio, TX.
19. Beck A.T., Steer R.A., Brown G.K. Depression Inventory: Manual 1996, BDI, B-II, Harcourt, Brace, and Company, Boston. 2nd ed.
20. Steer R.A., Ball R., Ranieri W.F., Beck A.T. Further evidence for the Construct validity of the Beck Depression Inventory-II with psychiatric outpatients. Psychol Rep 1997, 80(2):443-446.
21. Steer R.A., Ball R., Ranieri W.F., Beck A.T. Dimensions of the Beck Depression Inventory-II in clinically depressed outpatients. J Clin Psychol 1999, 55(1):117-128.
22. Arnau R.C., Meagher M.W., Norris M.P., Bramson R. Psychometric evaluation of the beck Depression Inventory-II with primary care medical patients. Health Psychol 2001, 20(2):112-119.
23. Harris C.A., D'Eon J.L. Psychometric properties of the Beck Depression Inventory, 2nd edition (BDI-II) in individuals with chronic pain. Pain 2008, 137(3):609-622.
24. Trupin L., Tonner M.C., Yazdany J., Julian L.J., Criswell L.A., Katz P.P., et al. The role of individual and socioeconomic status in outcomes of systemic lupus erythematosus. J Rheumatol 2008, 35(9):1782-1788.
25. Navarette-Navarette N., Peralta-Ramírez M.I., Sabio-Sánchez J.M., Coín M.A., Robles-Ortega H., Hidalgo-Tenorio C., et al. Efficacy of cognitive behavioral therapy for the treatment of chronic stress in patients with lupus erythematosus: a randomized controlled trial. Psychother Psychosom 2010, 79(2):107-115.
26. Navarrete-Navarette N., Peralta-Ramírez M.I., Sabio J.M., Martínez-Egea I., Santos-Ruiz A., Jiménez-Alonso J. Quality of life predictor factors in patients with SLE and their modification after cognitive behavioral therapy. Lupus 2010, 19(14):1632-1639.
27. Goldenberg D.L. The interface of pain and mood disturbances in the rheumatic diseases. Semin Arthritis Rheum 2010, 40(1):15-31.
28. Katon W., Sullivan M., Walker E. Medical symptoms without identified pathology: relationship to psychiatric disorders, childhood and adult trauma, and personality traits. Ann Intern Med 2001, 134(9 Pt 2):917-925.
29. Wells K.B., Golding J.M., Burnam M.A. Psychiatric disorder and limitations in physical functioning in a sample of the los Angeles general population. Am J Psychiatry 1988, 145(6):712-717.
30. Dionne C.E., Koepsell T.D., Von Korff M., Deyo R.A., Barlow W.E., Checkoway H. Predicting long-term functional limitations among back pain patients in primary care settings. J Clin Epidemiol 1997, 50(1):31-43.
31. Cepoiu M., McCusker J., Cole M.G., Sewitch M., Belzile E., Ciampi A. Recognition of depression by non-psychiatric physicians: a systematic literature review and meta-analysis. J Gen Intern Med 2007, 23(1):25-36.
32. Perrot S., Maheu M., Javier R.M., Eschalier A., Coutaux A., LeBars M., et al. Guidelines for the use of antidepressants in painful rheumatic conditions. Eur J Pain 2006, 10(3):185-192.
33. Verdu B., Decosterd I., Buclin T., Stiefel F., Berney A. Antidepressants for the treatment of chronic pain. Drugs 2008, 68(18):2611-2632.